HYTN Innovations Pivot to GMP‑Certified Pharma: From Cannabis to European Drug Export
HYTN Innovations pivots from recreational cannabis to GMP‑certified pharma, launching HARd remediation to tap EU markets and boost high‑margin earnings.
3 minutes to read
